Journal of Applied Physiology, Vol 64, Issue 5 1837-1843, Copyright © 1988 by American Physiological Society

ARTICLES

Effects of aminophylline on hypoxemia-induced ventilatory depression in the cat

S. Javaheri, L. J. Teppema and J. A. Evers
Pulmonary Section, Veterans Administration Medical Center, Cincinnati, Ohio.

We designed experiments to evaluate changes in ventral medullary (VM) extracellular fluid (ECF) PCO2 and pH during hypoxemia-induced ventilatory depression (VD). Our aim was to investigate effects of aminophylline on VD and VM ECF acid-base variables. We used aminophylline because it inhibits adenosine, which is released within the brain during hypoxemia and could mediate VD. Experiments were performed in seven cats with acute bilateral denervation of carotid sinus nerves and vagi. Cats were anesthetized with chloralose-urethan and breathed spontaneously at a regulated and elevated arterial PCO2 (PaCO2). Measurements were made during normoxemia, hypoxemia, and recovery before (phase I) and after (phase II) aminophylline. By use of strict criteria for definition of VD, during phase II two kinds of responses were observed. Aminophylline prevented VD in five cats. In these cats in phase I, with mean arterial PO2 (PaO2) = 105 and PaCO2 = 42.2 Torr, VM ECF PCO2, [H+], and [HCO3-] were 59.5 +/- 8.6 Torr (mean +/- SD), 60.2 +/- 9.4 neq/l, and 23.1 +/- 3.7 meq/l, respectively. When mean PaO2 dropped to 49 Torr, ventilation decreased 21%, with only small changes in VM ECF acid-base variables. Studies were repeated 30 min after aminophylline (17 mg/kg iv). In phase II, during normoxemia (PaO2 = 110 Torr) VM ECF Pco2, [H+], and [HCO3-] were 55.4 +/- 8.1 Torr, 62.0 +/- 8.0 neq/l and 20.7 +/- 2.5 meq/l, respectively. During hypoxemia (PaO2 = 48 +/- 4 Torr) mean ventilation, VM ECF PCO2, [H+], and [HCO3-] did not change significantly.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				S. Andreas, H. Reiter, L. Luthje, A. Delekat, R. W. Grunewald, G. Hasenfuss, and V. K. Somers Differential Effects of Theophylline on Sympathetic Excitation, Hemodynamics, and Breathing in Congestive Heart Failure Circulation, October 12, 2004; 110(15): 2157 - 2162. [Abstract] [Full Text] [PDF]

				R. Fischer, S.M. Lang, M. Leitl, M. Thiere, U. Steiner, and R.M. Huber Theophylline and acetazolamide reduce sleep-disordered breathing at high altitude Eur. Respir. J., January 1, 2004; 23(1): 47 - 52. [Abstract] [Full Text] [PDF]

				C. A. Pesek, R. Cooley, K. Narkiewicz, M. Dyken, N. L. Weintraub, and V. K. Somers Theophylline Therapy for Near-Fatal Cheyne-Stokes Respiration: A Case Report Ann Intern Med, March 2, 1999; 130(5): 427 - 430. [Abstract] [Full Text] [PDF]

				S. Javaheri, T.J. Parker, L. Wexler, J.D. Liming, P. Lindower, and G.A. Roselle Effect of Theophylline on Sleep-Disordered Breathing in Heart Failure N. Engl. J. Med., August 22, 1996; 335(8): 562 - 567. [Abstract] [Full Text] [PDF]